Spineart and eCential Robotics Receive FDA Clearance for PERLA TL Spine App

Aug 26, 2026
Spineart and eCential Robotics received FDA 510(k) clearance for the PERLA TL application for use with the eCential Op.n navigation and robotics platform.

Spineart and eCential Robotics said in a press release that the U.S. FDA granted 510(k) clearance for the PERLA TL application for use with the eCential Op.n navigation and robotics platform.

The clearance adds robotic workflow use for PERLA TL, which was already compatible with the Op.n navigation platform. The system is intended to support placement of PERLA TL Open and MIS pedicle screw systems in open and minimally invasive spine procedures.

The PERLA app runs on the Op.n platform and combines Spineart implant technology with eCential Robotics navigation and robotic assistance. The companies said the app will be displayed at the Spineart Innovation Center in Dallas.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Robotics Brief, Life AI Weekly or Daily AI Brief.

Free newsletter

Robotics Brief

Weekly coverage of AI-driven robotics advances in industrial automation, autonomous vehicles, and robotic systems.

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.